Generics Maker Says Drug-Safety Program Gets Abused

Law360, New York (November 13, 2009, 4:06 PM EST) -- Teva Pharmaceuticals Ltd. has reportedly complained to the Federal Trade Commission that it has been unable to purchase bulk quantities of certain pharmaceuticals because brand-name drug companies are using a federal drug-safety program to unfairly limit competition.

The program, enacted in 2007, limits the sale of certain riskier drugs in an effort to guard against abuse. But Teva said in a letter to the FTC that GlaxoSmithKline PLC, Novartis AG and Bayer AG had all refused to sell the Israel-based generics maker supplies of certain drugs,...
To view the full article, register now.